핵심기술
특허 / 논문
- 번호 제목
- 225 Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
- 224 Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.
- 223 Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody.
- 222 CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
- 221 Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
- 220 Role of endogenous 4-1BB in the development of systemic lupus erythematosus.
- 219 Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages.
- 218 Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages.
- 217 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
- 216 Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.